The Nature of Prefrontal Cortical GABA Neuron Alterations in Schizophrenia: Markedly Lower Somatostatin and Parvalbumin Gene Expression Without Missing Neurons.
暂无分享,去创建一个
[1] Nikola Habek,et al. Upper cortical layer–driven network impairment in schizophrenia , 2022, Science advances.
[2] V. Sohal. Transforming Discoveries About Cortical Microcircuits and Gamma Oscillations Into New Treatments for Cognitive Deficits in Schizophrenia. , 2022, The American journal of psychiatry.
[3] G. Reynolds. The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin , 2021, Journal of Neural Transmission.
[4] J. Gore,et al. mGlu1 potentiation enhances prelimbic somatostatin interneuron activity to rescue schizophrenia-like physiological and cognitive deficits , 2021, Cell reports.
[5] Anne E Carpenter,et al. CellProfiler 4: improvements in speed, utility and usability , 2021, BMC Bioinformatics.
[6] C. Carter,et al. Mechanisms underlying dorsolateral prefrontal cortex contributions to cognitive dysfunction in schizophrenia , 2021, Neuropsychopharmacology.
[7] E. Sibille,et al. Behavioral Deficits Induced by Somatostatin-Positive GABA Neuron Silencing Are Rescued by Alpha 5 GABA-A Receptor Potentiation , 2021, The international journal of neuropsychopharmacology.
[8] S. Dienel,et al. Distinct Laminar and Cellular Patterns of GABA Neuron Transcript Expression in Monkey Prefrontal and Visual Cortices. , 2020, Cerebral cortex.
[9] Christian Keysers,et al. Using Bayes factor hypothesis testing in neuroscience to establish evidence of absence , 2020, Nature Neuroscience.
[10] J. Glausier,et al. Diagnosis- and Cell Type-Specific Mitochondrial Functional Pathway Signatures in Schizophrenia and Bipolar Disorder , 2020, Biological Psychiatry.
[11] P. Tooney,et al. Reduced cortical somatostatin gene expression in a rat model of maternal immune activation , 2019, Psychiatry Research.
[12] D. Lewis,et al. Alterations in cortical interneurons and cognitive function in schizophrenia , 2019, Neurobiology of Disease.
[13] O. Howes,et al. Pre-frontal parvalbumin interneurons in schizophrenia: a meta-analysis of post-mortem studies , 2019, Journal of Neural Transmission.
[14] P. Tooney,et al. White matter neuron biology and neuropathology in schizophrenia , 2019, npj Schizophrenia.
[15] A. Buonanno,et al. Detection and Quantification of Multiple RNA Sequences Using Emerging Ultrasensitive Fluorescent In Situ Hybridization Techniques , 2019, Current protocols in neuroscience.
[16] J. Gordon,et al. Somatostatin Interneurons Facilitate Hippocampal-Prefrontal Synchrony and Prefrontal Spatial Encoding , 2018, Neuron.
[17] T. Hashimoto,et al. Expression of Transcripts Selective for GABA Neuron Subpopulations across the Cortical Visuospatial Working Memory Network in the Healthy State and Schizophrenia. , 2018, Cerebral cortex.
[18] H. Bazmi,et al. Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders , 2018, Neuropsychopharmacology.
[19] A. Wong,et al. GABAergic inhibitory neurons as therapeutic targets for cognitive impairment in schizophrenia , 2018, Acta Pharmacologica Sinica.
[20] K. Fish,et al. Laminar Distribution of Subsets of GABAergic Axon Terminals in Human Prefrontal Cortex , 2018, Front. Neuroanat..
[21] Per B. Brockhoff,et al. lmerTest Package: Tests in Linear Mixed Effects Models , 2017 .
[22] H. H. Hulshoff Pol,et al. GABAergic Mechanisms in Schizophrenia: Linking Postmortem and In Vivo Studies , 2017, Front. Psychiatry.
[23] G. Dragoi,et al. Impaired Tuning of Neural Ensembles and the Pathophysiology of Schizophrenia: A Translational and Computational Neuroscience Perspective , 2017, Biological Psychiatry.
[24] Michael Lagler,et al. Divisions of Identified Parvalbumin-Expressing Basket Cells during Working Memory-Guided Decision Making , 2016, Neuron.
[25] K. Fish,et al. Pathological Basis for Deficient Excitatory Drive to Cortical Parvalbumin Interneurons in Schizophrenia. , 2016, The American journal of psychiatry.
[26] K. Fish,et al. Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia , 2016, Biological Psychiatry.
[27] Benjamin A. Logsdon,et al. Gene Expression Elucidates Functional Impact of Polygenic Risk for Schizophrenia , 2016, Nature Neuroscience.
[28] Kafui Dzirasa,et al. Animal models of psychiatric disorders , 2016, Neuroscience.
[29] T. Sigurdsson,et al. Neural circuit dysfunction in schizophrenia: Insights from animal models , 2016, Neuroscience.
[30] K. Fish,et al. Reduced Labeling of Parvalbumin Neurons and Perineuronal Nets in the Dorsolateral Prefrontal Cortex of Subjects with Schizophrenia , 2016, Neuropsychopharmacology.
[31] Alan S. Brown,et al. Maternal Immune Activation Leads to Selective Functional Deficits in Offspring Parvalbumin Interneurons , 2015, Molecular Psychiatry.
[32] A. Sampson,et al. Dysregulated ErbB4 Splicing in Schizophrenia: Selective Effects on Parvalbumin Expression. , 2015, The American journal of psychiatry.
[33] H. Bazmi,et al. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene. , 2015, JAMA psychiatry.
[34] C. Shannon Weickert,et al. Relationship between somatostatin and death receptor expression in the orbital frontal cortex in schizophrenia: a postmortem brain mRNA study , 2015, npj Schizophrenia.
[35] T. Woo,et al. Transcriptional dysregulation of γ-aminobutyric acid transporter in parvalbumin-containing inhibitory neurons in the prefrontal cortex in schizophrenia , 2014, Psychiatry Research.
[36] Aiqing He,et al. Distinctive transcriptome alterations of prefrontal pyramidal neurons in schizophrenia and schizoaffective disorder , 2014, Molecular Psychiatry.
[37] A. Grace,et al. The role of α5 GABAA receptor agonists in the treatment of cognitive deficits in schizophrenia. , 2014, Current pharmaceutical design.
[38] D. Bates,et al. Fitting Linear Mixed-Effects Models Using lme4 , 2014, 1406.5823.
[39] M. Webster,et al. Schizophrenia and bipolar disorder show both common and distinct changes in cortical interneuron markers , 2014, Schizophrenia Research.
[40] M. Stryker,et al. Interneurons from Embryonic Development to Cell-Based Therapy , 2014, Science.
[41] Pico Caroni,et al. Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning , 2013, Nature.
[42] J. Rubenstein,et al. Subcortical origins of human and monkey neocortical interneurons , 2013, Nature Neuroscience.
[43] S. Anderson,et al. Losing your inhibition: Linking cortical GABAergic interneurons to schizophrenia , 2013, Neurobiology of Disease.
[44] Christopher H Woelk,et al. A combined analysis of microarray gene expression studies of the human prefrontal cortex identifies genes implicated in schizophrenia. , 2012, Journal of psychiatric research.
[45] Danko D. Georgiev,et al. Deficits in transcriptional regulators of cortical parvalbumin neurons in schizophrenia. , 2012, The American journal of psychiatry.
[46] A. Stan,et al. Altered cortical GABA neurotransmission in schizophrenia: insights into novel therapeutic strategies. , 2012, Current pharmaceutical biotechnology.
[47] D. Lewis,et al. NMDA receptor hypofunction, parvalbumin-positive neurons, and cortical gamma oscillations in schizophrenia. , 2012, Schizophrenia bulletin.
[48] F. Knoflach,et al. Beyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes , 2011, Nature Reviews Drug Discovery.
[49] C. Weickert,et al. Lack of Change in Markers of Presynaptic Terminal Abundance Alongside Subtle Reductions in Markers of Presynaptic Terminal Plasticity in Prefrontal Cortex of Schizophrenia Patients , 2011, Biological Psychiatry.
[50] M. Webster,et al. Expression of interneuron markers in the dorsolateral prefrontal cortex of the developing human and in schizophrenia. , 2010, The American journal of psychiatry.
[51] S. Hyman,et al. Animal models of neuropsychiatric disorders , 2010, Nature Neuroscience.
[52] Jens Hjerling-Leffler,et al. The Cell-Intrinsic Requirement of Sox6 for Cortical Interneuron Development , 2009, Neuron.
[53] J. D. Macklis,et al. SOX6 controls dorsal-ventral progenitor parcellation and interneuron diversity during neocortical development , 2009, Nature Neuroscience.
[54] H. M. Morris,et al. Alterations in somatostatin mRNA expression in the dorsolateral prefrontal cortex of subjects with schizophrenia or schizoaffective disorder. , 2008, Cerebral cortex.
[55] H. Akiyama,et al. Changes in density of calcium‐binding‐protein‐immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder , 2008, Neuropathology : official journal of the Japanese Society of Neuropathology.
[56] H. M. Morris,et al. Alterations in GABA-related transcriptome in the dorsolateral prefrontal cortex of subjects with schizophrenia , 2008, Molecular Psychiatry.
[57] Tony O’Hagan. Bayes factors , 2006 .
[58] P. Tooney,et al. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia , 2004, Progress in Neuro-Psychopharmacology and Biological Psychiatry.
[59] David A Lewis,et al. Pyramidal neuron local axon terminals in monkey prefrontal cortex: differential targeting of subclasses of GABA neurons. , 2003, Cerebral cortex.
[60] A. Sampson,et al. Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.
[61] T. Woo,et al. Schizophrenia and the parvalbumin-containing class of cortical local circuit neurons. , 1997, The American journal of psychiatry.
[62] E. G. Jones,et al. Maldistribution of interstitial neurons in prefrontal white matter of the brains of schizophrenic patients. , 1996, Archives of general psychiatry.
[63] S. Hendry,et al. Regulation of calcium-binding protein immunoreactivity in GABA neurons of macaque primary visual cortex. , 1996, Cerebral cortex.
[64] L. Benevento,et al. Gamma-aminobutyric acid and somatostatin immunoreactivity in the visual cortex of normal and dark-reared rats , 1995, Brain Research.
[65] E. G. Jones,et al. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.
[66] J. DeFelipe,et al. Neocortical neuronal diversity: chemical heterogeneity revealed by colocalization studies of classic neurotransmitters, neuropeptides, calcium-binding proteins, and cell surface molecules. , 1993, Cerebral cortex.
[67] F. Benes,et al. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. , 1991, Archives of general psychiatry.
[68] A. Sampson,et al. Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance. , 2015, Schizophrenia bulletin.
[69] J. Flanagan,et al. RNAscope: a novel in situ RNA analysis platform for formalin-fixed, paraffin-embedded tissues. , 2012, The Journal of molecular diagnostics : JMD.
[70] J. Moreau,et al. RO4938581, a novel cognitive enhancer acting at GABAA α5 subunit-containing receptors , 2008, Psychopharmacology.
[71] David A Lewis,et al. GABA Targets for the Treatment of Cognitive Dysfunction in Schizophrenia. , 2005, Current neuropharmacology.